NCT02919371 2018-08-10
Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)
King Faisal Specialist Hospital & Research Center
Phase 1/2 Unknown
King Faisal Specialist Hospital & Research Center
Consorzio Oncotech
National Cancer Institute (NCI)
Australasian Sarcoma Study Group
Hadassah Medical Organization
Campania Younger Oncologists Association